Annual Cash & Cash Equivalents
$2.34 M
-$477.00 K-16.94%
December 1, 2024
Summary
- As of March 9, 2025, ARTL annual cash & cash equivalents is $2.34 million, with the most recent change of -$477.00 thousand (-16.94%) on December 1, 2024.
- During the last 3 years, ARTL annual cash & cash equivalents has fallen by -$9.82 million (-80.78%).
- ARTL annual cash & cash equivalents is now -80.78% below its all-time high of $12.16 million, reached on December 1, 2021.
Performance
ARTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.34 M
-$2.02 M-46.34%
December 1, 2024
Summary
- As of March 9, 2025, ARTL quarterly cash and cash equivalents is $2.34 million, with the most recent change of -$2.02 million (-46.34%) on December 1, 2024.
- Over the past year, ARTL quarterly cash and cash equivalents has increased by +$1.46 million (+165.38%).
- ARTL quarterly cash and cash equivalents is now -83.36% below its all-time high of $14.05 million, reached on November 30, 2021.
Performance
ARTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ARTL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.9% | +165.4% |
| 3 y3 years | -80.8% | -83.4% |
| 5 y5 years | +9.2% | -68.4% |
ARTL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.8% | at low | -80.8% | +165.4% |
| 5 y | 5-year | -80.8% | +9.2% | -83.4% | +165.4% |
| alltime | all time | -80.8% | >+9999.0% | -83.4% | >+9999.0% |
Artelo Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.34 M(-16.9%) | $2.34 M(-46.3%) |
| Sep 2024 | - | $4.36 M(+394.6%) |
| Jun 2024 | - | $881.00 K(-26.3%) |
| Mar 2024 | - | $1.20 M(-57.5%) |
| Dec 2023 | $2.81 M(-59.1%) | $2.81 M(+6.7%) |
| Sep 2023 | - | $2.64 M(-53.9%) |
| Jun 2023 | - | $5.72 M(-17.3%) |
| Mar 2023 | - | $6.92 M(+0.4%) |
| Dec 2022 | $6.89 M(-43.4%) | $6.89 M(-3.5%) |
| Sep 2022 | - | $7.14 M(-41.1%) |
| Jun 2022 | - | $12.12 M(+17.1%) |
| Mar 2022 | - | $10.35 M(-14.9%) |
| Dec 2021 | $12.16 M(+83.5%) | $12.16 M(-13.4%) |
| Nov 2021 | - | $14.05 M(+111.9%) |
| Aug 2021 | $6.63 M(+209.5%) | $6.63 M(-34.1%) |
| May 2021 | - | $10.05 M(-6.1%) |
| Feb 2021 | - | $10.71 M(+44.9%) |
| Nov 2020 | - | $7.39 M(+244.9%) |
| Aug 2020 | $2.14 M | $2.14 M(+67.4%) |
| May 2020 | - | $1.28 M(-35.5%) |
| Feb 2020 | - | $1.98 M(-41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2019 | - | $3.37 M(-23.7%) |
| Aug 2019 | $4.42 M(+1211.2%) | $4.42 M(+1444.7%) |
| May 2019 | - | $286.40 K(-37.4%) |
| Feb 2019 | - | $457.30 K(+297.3%) |
| Nov 2018 | - | $115.10 K(-65.9%) |
| Aug 2018 | $337.40 K(-41.1%) | $337.40 K(+3.5%) |
| May 2018 | - | $326.00 K(-37.9%) |
| Feb 2018 | - | $525.10 K(+27.3%) |
| Nov 2017 | - | $412.40 K(-28.0%) |
| Aug 2017 | $572.80 K(>+9900.0%) | $572.80 K(+151.4%) |
| May 2017 | - | $227.80 K(+1989.9%) |
| Feb 2017 | - | $10.90 K(+202.8%) |
| Nov 2016 | - | $3600.00(0.0%) |
| Aug 2016 | $3600.00(-78.8%) | $3600.00(0.0%) |
| May 2016 | - | $3600.00(0.0%) |
| Feb 2016 | - | $3600.00(-10.0%) |
| Nov 2015 | - | $4000.00(-76.5%) |
| Aug 2015 | $17.00 K(+15.6%) | $17.00 K(+34.9%) |
| May 2015 | - | $12.60 K(+55.6%) |
| Feb 2015 | - | $8100.00(-44.9%) |
| Aug 2014 | $14.70 K | $14.70 K |
FAQ
- What is Artelo Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Artelo Biosciences?
- What is Artelo Biosciences annual cash & cash equivalents year-on-year change?
- What is Artelo Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash and cash equivalents year-on-year change?
What is Artelo Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ARTL is $2.34 M
What is the all time high annual cash & cash equivalents for Artelo Biosciences?
Artelo Biosciences all-time high annual cash & cash equivalents is $12.16 M
What is Artelo Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, ARTL annual cash & cash equivalents has changed by -$477.00 K (-16.94%)
What is Artelo Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARTL is $2.34 M
What is the all time high quarterly cash and cash equivalents for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash and cash equivalents is $14.05 M
What is Artelo Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ARTL quarterly cash and cash equivalents has changed by +$1.46 M (+165.38%)